ASTRO Guideline on Stereotactic Body Radiation Therapy (SBRT) for Early Stage Non-small Cell Lung Cancer (NSCLC)

Published: September 2017 (Web posted June 2017)

Read Executive Summary
Read Full-Text Guideline

This guideline evaluates the following four key questions regarding SBRT inch allenging clinical scenarios in early-stage NSCLC: 1) application of SBRT to operable patients; 2) appropriate use of SBRT in tumors that are centrally located, large, multifocal or unbiopsied, and 3) in individual tailoring of SBRT in “high-risk” clinical scenarios; and 4) SBRT as salvage therapy after recurrence.

Endorsed by:

• American Society of Clinical Oncology
• European Society for Radiotherapy and Oncology
• The Royal Australian and New Zealand College of Radiologists

Key Points:

• SBRT as alternative to surgery
• SBRT techniques for medically inoperable patients

Resources:

Comparison of the Effectiveness of Radiofrequency Ablation with SBRT in Inoperable Stage I NSCLC (CME)
ASTRO’s SBRT Model Policy 
Patient Brochure